Drug

Who makes carboplatin?

11 companies list carboplatin as a human prescription drug, including under the names KYXATA. Forms: injection; injection, solution. Routes: intravenous.

Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology

Companies listing carboplatin

CompanyFormsApplicationNDCsRegistered sites
Hospira, Inc.United Statesinjection, solutionANDAANDA076517, ANDA07705957
NATCO PHARMA LIMITEDIndiainjection, solutionANDAANDA07786145
GLAND PHARMA LIMITEDIndiainjection, solutionANDAANDA20732444
BPI Labs, DBA Ally LabsUnited Statesinjection, solutionANDAANDA20732442
Teyro Labs Private LimitedIndiainjection, solutionANDAANDA07786141
Eugia US LLCinjection, solutionANDAANDA20548740
Teva Parenteral Medicines, Inc.injection, solutionANDAANDA07726940
Avyxa GmbHSwitzerlandinjectionNDANDA21992121
Apotex Inc.Canadainjection, solutionANDAANDA07786116
Fresenius Kabi USA, LLCUnited Statesinjection, solutionANDAANDA07726616
ACCORD HEALTHCARE LIMITEDUnited KingdominjectionANDAANDA20677512

Bulk ingredient listings

Orange Book patents

1 unexpired patent lists carboplatin as the active ingredient, expiring between Apr 2045 and Apr 2045. Application holder: AVYXA HOLDINGS LLC.

Enquiry

Common questions

Who makes carboplatin?
11 companies list carboplatin as a human prescription drug in the openFDA NDC Directory, led by Hospira, Inc., NATCO PHARMA LIMITED, GLAND PHARMA LIMITED, BPI Labs, DBA Ally Labs, Teyro Labs Private Limited. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
Is there a generic KYXATA?
10 companies list carboplatin under an abbreviated new drug application (ANDA), the application type used for generics, and 1 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.
Who supplies carboplatin active ingredient?
7 companies list carboplatin as a bulk ingredient, including CIPLA PHARMACEUTICALS LIMITED, Heraeus Precious Metals GmbH Co KG, Hetero Labs Limited, Sicor de Mexico S.A. de C.V..